The AI-powered tool DERM, developed by Skin Analytics, has received the first-ever regulatory approval to independently assess skin cancer risk from photos — without direct human oversight. Previously, it was used alongside dermatologists, but now it’s legally authorized to make clinical decisions on its own. The system analyzes images of lesions to determine malignancy risk. This milestone marks a significant shift in preventive healthcare, potentially making skin cancer screening more accessible, though experts emphasize it should complement, not replace, in-person exams.
About the Author
